Boston Scientific Corp: FDA filings under this applicant name
FDA lists 731 510(k) clearances under 5 spellings of the applicant name “Boston Scientific Corp” (first 1988, latest 2026), plus 75 PMA and 2 De Novo decisions, across 175 product codes in 13 review panels. Median 510(k) review time under this name: 77 days. Since 2017 the median was 77 days, against 110 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Boston Scientific, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 28 | 88 |
| 2013 | 21 | 84 |
| 2014 | 34 | 82 |
| 2015 | 25 | 79 |
| 2016 | 15 | 67 |
| 2017 | 25 | 89 |
| 2018 | 17 | 90 |
| 2019 | 18 | 58 |
| 2020 | 19 | 74 |
| 2021 | 18 | 108 |
| 2022 | 16 | 74 |
| 2023 | 25 | 84 |
| 2024 | 14 | 76 |
| 2025 | 16 | 29 |
| 2026 | 17 | 56 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Boston Scientific Corp took a median 77 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 110 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| FGE | Stents, Drains And Dilators For The Biliary Ducts | 56 | 56 |
| LIT | Catheter, Angioplasty, Peripheral, Transluminal | 52 | 52 |
| DQX | Wire, Guide, Catheter | 34 | 34 |
| DQY | Catheter, Percutaneous | 30 | 30 |
| DQO | Catheter, Intravascular, Diagnostic | 20 | 20 |
| KNS | Unit, Electrosurgical, Endoscopic (With Or Without Accessories) | 18 | 18 |
| DYB | Introducer, Catheter | 16 | 16 |
| KRD | Device, Vascular, For Promoting Embolization | 16 | 16 |
| DQK | Computer, Diagnostic, Programmable | 15 | 15 |
| ESW | Prosthesis, Esophageal | 15 | 15 |
Plus 165 more product codes.
Review panels
- Cardiovascular (372)
- Gastroenterology and Urology (293)
- General and Plastic Surgery (48)
- Radiology (26)
- Ear, Nose and Throat (14)
- Neurology (14)
- Obstetrics and Gynecology (14)
- General Hospital (13)
- Anesthesiology (8)
- Immunology (2)
- Orthopedic (2)
- Physical Medicine (1)
- Clinical Toxicology (1)
Most recent Boston Scientific Corp 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K262151 | SpaceOAR Flex System | OVB | 2026-09-11 | 78 |
| K262460 | Rezum System | KNS | 2026-09-03 | 48 |
| K261153 | LithoVue Elite Digital Flexible Ureteroscope System | FGB | 2026-08-26 | 140 |
| K253692 | AVVIGO+ Multi-Modality Guidance System | DQK | 2026-08-21 | 273 |
| K262406 | EluPro Antibiotic-Eluting BioEnvelope | FTM | 2026-08-12 | 28 |
| K261915 | Navigator Flex Ureteral Access Sheath Set | FED | 2026-08-04 | 56 |
| K262462 | TheraSphere 360 Y-90 Management Platform | LLZ | 2026-07-24 | 7 |
| K262165 | FARADRIVE Steerable Sheath (M004PF21M402) | DRA | 2026-07-24 | 28 |
| K261488 | OBSIDIO Conformable Embolic | KRD | 2026-07-24 | 79 |
| K261978 | WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System | ESW | 2026-07-10 | 28 |
721 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P130030 | PMA | REBEL PLATINUM CHROMIUM CORONARY STENT SYSTEM MONORAIL AND OVER THE WIRE | 2026-03-10 |
| P230035 | PMA | AGENT Paclitaxel-Coated Balloon Catheter | 2024-02-29 |
| DEN230019 | De Novo | Gallbladder Drainage Stent And Delivery System | 2023-08-18 |
| P220032 | PMA | POLARx/POLARx FIT Cryoablation Catheters, SMARTFREEZE Cryoablation Console, Accessories | 2023-08-08 |
| P200036 | PMA | eCoin Peripheral Neurostimulator | 2022-03-01 |
Recalls
1,256 product recalls in 311 recall events; 348 initiated in the last five years. Most recent: 2026-09-10.
234 product recalls in 90 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 53 initiated in the last five years. Most often: Boston Scientific CRM Corp (55), Boston Scientific Cork, Ltd. (41), Guidant Corporation (28).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Boston Scientific Corp is the lead sponsor of 487 device studies on ClinicalTrials.gov (70 active or recruiting). Most recent:
- NCT07639684: Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D) (Not yet recruiting, started 2027-04)
- NCT07458243: A Prospective, Multicenter, Single Arm Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT in Chinese Population (Not yet recruiting, started 2027-02-28)
- NCT07925359: The Evaluation of User Experience With FARAVIEW™ Technology of the OPAL HDx™ Mapping System When Used With the FARAWAVE NAV™ ULTRA Pulsed Field Ablation Catheter in the Treatment of Atrial Fibrillation (Not yet recruiting, started 2027-01-20)
- NCT07669727: A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning. (Not yet recruiting, started 2027-01)
- NCT07711093: Study of Eso-SPONGE for Treating Leaks After Upper Gastrointestinal Surgery (Not yet recruiting, started 2026-12)
Parent company SEC filings
BOSTON SCIENTIFIC CORP (BSX): EDGAR filings, CIK 885725. Caduvo groups Boston Scientific Corp under Boston Scientific; the parent's SEC registrant is entered by hand for the group, not matched by name.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Boston Scientific Corp (a text match, not an official crosswalk):
- C1767 — Generator, neurostimulator (implantable), non-rechargeable (via LWP)
- C9602 — Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch (via OOB)
- L8678 — Electrical stimulator supplies (external) for use with implantable neurostimulator, per month (via EZW)
- C9600 — Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch (via OOB)
- C9603 — Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) (via OOB)
FDA spellings included
FDA records this applicant under 5 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Boston Scientific Corp (468)
- Boston Scientific Corporation (256)
- Boston Scientific (82)
- Boston Scientific Corporation - (1)
- Boston Scientific, Inc. (1)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Boston Scientific Scimed, Inc. (35 510(k)s)
- Boston Medical Products, Inc. (33 510(k)s)
- Boston Scientific, Target (19 510(k)s)
- Boston Surgical Products, Inc. (17 510(k)s)
- Boston Biomedica, Inc. (12 510(k)s)
- Boston Pacific Medical, Inc. (11 510(k)s)
- Boston Scientific Neuromodulation (10 510(k)s)
- Boston Medical Corp. (8 510(k)s)
- Boston Aesthetics, Inc. (6 510(k)s)
- The Boston Medical Group (5 510(k)s)
- Boston Scientific /International Technologies (5 510(k)s)
- Boston Scientific/Medi-Tech (5 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Boston Scientific Corp?
FDA lists 731 510(k) clearances under 5 spellings of the applicant name “Boston Scientific Corp” (first 1988, latest 2026), plus 75 PMA and 2 De Novo decisions, across 175 product codes in 13 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Boston Scientific Corp?
The median time from FDA receipt to decision across 510(k)s cleared under the name Boston Scientific Corp is 77 days. Since 2017: 77 days, versus 110 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Boston Scientific Corp?
The most frequent FDA product codes under this applicant name are FGE (Stents, Drains And Dilators For The Biliary Ducts, 56); LIT (Catheter, Angioplasty, Peripheral, Transluminal, 52); DQX (Wire, Guide, Catheter, 34).
Next steps
- See all 731 Boston Scientific Corp clearances with predicates and recalls
- Run predicate analysis for product code FGE, Boston Scientific Corp's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.